fashion -WSS

fashion

author：Wikipedia 2025-10-02 22:24:43 - browse：65276

A sign of pharmaceutical company Bayer in front of a blossomed tree — coverage from STAT — INA FASSBENDER/AFP via Getty Images

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S. Food and Drug Administration last spring and received approval in the U.K., under the name Veozah, in December.

Elinzanetant is a neurokinin-1 and 3 receptor antagonist, and works by calming down the estrogen receptors in the brain that become hyperactive around menopause, causing hot flashes. The drug, a pill administered once a day, was shown to reduce both the frequency and intensity of hot flashes, and also met the secondary endpoints for improving sleep and quality of life, according to JoAnn Pinkerton, professor of obstetrics and gynecology and director of the Midlife Health at UVA Health, who is a clinical investigator for Bayer’s drug candidate.

Pinkerton said she was excited to see the broader quality of life improvements through elinzanetant: “Women have more than just hot flashes — it’s actually more about hot flushes, sweats, fatigue, lack of sleep and some of the mood changes that go on during [menopause].”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： 'Ancient DNA,' 23andMe reveal African American ancestries

leisure time

WSS

Sanofi CEO defends move to abandon profit guidance, boost research

White House drug shortage group privately met with industry

Humana, CVS hope to turn members into patients at clinics

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

ProMED, early warning system on disease outbreaks, in peril

Victims of gun violence feel impacts long after bullet wound

entertainment

fashion

leisure time

Medical records are filled with copy

Influencer to be charged after chaos erupts in New York City's Union Square

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Will General Catalyst be the first of many hospital takeovers?

Medical records are filled with copy

White House calls on federal agencies to crack down on AI abuses

Medicare proposal to cover medical devices draws a mixed reaction

Ambulance rides for just $100? Advisers want major billing fixes

Jerome Adams on the need for new antivirals for Covid

What the cancer research community can learn from the Covid response

hotspot

ProMED, early warning system on disease outbreaks, in peril

Senate panel clears PBM, hopsital reforms

MoonLake credibility takes another hit with mid

Biden calls for immediate release of Niger's president amid apparent coup

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Microsoft strikes partnership with Duke Health to advance health AI

hotspot

focus

leisure time

explore